22 Oct 2024
// GLOBENEWSWIRE
10 Dec 2024
// PRESS RELEASE
10 Dec 2024
// PRESS RELEASE
Latest Content by PharmaCompass
01 1AZELASTINE HYDROCHLORIDE USP
02 1BUDESONIDE
03 1CICLESONIDE
04 1DEFLAZACORT
05 1EXEMESTANE
06 1FLUTICASONE FUROATE
07 1FLUTICASONE FUROATE (PROCESS 1)
08 1FLUTICASONE PROPIONATE
09 1FLUTICASONE PROPIONATE (PROCESS 1)
10 1FORMOTEROL FUMARATE DIHYDRATE
11 1MOMETASONE FUROATE
12 1MOMETASONE FUROATE MONOHYDRATE
13 1MOMETASONE FUROATE USP (PROCESS I)
14 1TRIAMCINOLONE ACETONIDE
15 1TRIAMCINOLONE HEXACETONIDE
01 11CORAL DRUGS PRIVATE LTD
02 4CORAL DRUGS PVT LTD
01 15India
01 15Active
01 4Complete
02 11Blank
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-01
Pay. Date : 2023-09-22
DMF Number : 36205
Submission : 2021-10-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30534
Submission : 2017-02-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38283
Submission : 2023-04-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-20
Pay. Date : 2023-11-22
DMF Number : 38936
Submission : 2023-10-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38247
Submission : 2023-03-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32040
Submission : 2017-10-02
Status : Active
Type : II